CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test
Introduction
The CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test is a specialized diagnostic tool designed to assess genetic predisposition to melanoma, a serious form of skin cancer. This test utilizes Next-Generation Sequencing (NGS) technology to analyze the CDKN2A gene, which is associated with familial melanoma syndromes. Understanding your genetic risk can empower proactive health decisions and early interventions.
What the Test Measures
This test specifically detects mutations in the CDKN2A gene that may increase the risk of developing melanoma. By identifying these mutations, healthcare providers can better understand an individual’s risk profile.
Who Should Consider This Test
Individuals who have a family history of melanoma or other skin cancers are prime candidates for this test. Symptoms indicating a need for testing include:
- A family history of melanoma.
- Multiple or atypical moles.
- Personal history of skin cancer.
- Fair skin, light hair, and light eye color.
Benefits of Taking the Test
- Identifies genetic risks for melanoma, enabling early monitoring and intervention.
- Provides essential information for family members who may also be at risk.
- Guides healthcare providers in creating personalized prevention and treatment strategies.
Understanding Your Results
Results from the CDKN2A Gene Melanoma test can help you and your healthcare team understand your risk for melanoma. A positive result indicates an increased risk, while a negative result suggests a lower risk. However, it is essential to consult with a genetic counselor or oncologist to interpret results accurately and discuss potential next steps.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a clinical history and a genetic counseling session are recommended to construct a pedigree chart of family members affected by melanoma.
Book Your Test Today!
We have branches across Kenya, including major cities like Nairobi and Mombasa, and we offer home sample collection services. To schedule your CDKN2A Gene Melanoma Cutaneous Malignant Familial NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
